Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) R&D In Process: 2013-2023

Historic R&D In Process for Fortress Biotech (FBIO) over the last 8 years, with Dec 2023 value amounting to $31,000.

  • Fortress Biotech's R&D In Process fell 95.25% to $31,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $4.3 million, marking a year-over-year increase of 197.80%. This contributed to the annual value of $300,000 for FY2024, which is 93.06% down from last year.
  • As of Q4 2023, Fortress Biotech's R&D In Process stood at $31,000, which was down 48.33% from $60,000 recorded in Q3 2023.
  • Fortress Biotech's R&D In Process' 5-year high stood at $14.9 million during Q1 2020, with a 5-year trough of $3,000 in Q2 2023.
  • In the last 3 years, Fortress Biotech's R&D In Process had a median value of $93,000 in 2021 and averaged $1.7 million.
  • Its R&D In Process has fluctuated over the past 5 years, first surged by 3,203.78% in 2020, then crashed by 99.15% in 2021.
  • Quarterly analysis of 5 years shows Fortress Biotech's R&D In Process stood at $450,000 in 2019, then surged by 3,203.78% to $556,000 in 2020, then slumped by 92.81% to $40,000 in 2021, then soared by 1,530.00% to $652,000 in 2022, then slumped by 95.25% to $31,000 in 2023.
  • Its R&D In Process was $31,000 in Q4 2023, compared to $60,000 in Q3 2023 and $3,000 in Q2 2023.